eClinical Tech News

TheraVectys, a biotechnology company specializing in lentiviral vector-based vaccines and immunotherapies, has begun enrolling patients in a Phase I/IIa...

The Paris Commercial Court has granted an extension of receivership proceedings for ACTICOR Biotech, a biopharmaceutical company focused on...

Humanetics Corporation presented updates on the progress of BIO 300, an orally administered drug designed to prevent radiation toxicity...

Real Chemistry and Corval have forged a partnership to provide biopharma companies with an innovative platform for commercialization planning...

Maze Therapeutics, a biopharmaceutical company, has commenced its Phase 1 clinical trial for MZE782, an oral small molecule therapy....

Purdue Pharma has completed the initial phase of a study investigating the use of nalmefene hydrochloride injection (HCl) in...

INBRAIN Neuroelectronics has made history by performing the world’s first human procedure using its cortical brain-computer interface (BCI) in...

Vivani Medical announces the approval of its clinical trial for a miniature GLP-1 implant, designed to offer comparable effectiveness...

Epineuron has achieved a significant milestone with the approval of its PeriPulse™ system by Health Canada. This innovative nerve...

The Virtual Clinical Trials (VCT) market has surged to an estimated USD 2.64 billion in 2023, projected to reach...